ISB News

Three Collaborative Projects Announced for ISB’s 2022 Innovator Award Program

2022 Innovator Awards

ISB kicked off the sixth year of our successful Innovator Award Program by announcing three collaborative projects. This internal program is designed to support novel research ideas that cut across disciplines and research groups. Washington Research Foundation once again generously pledged $100,000 to fund the awards. ISB also received an additional $50,000 matching donation from a generous donor.

WRF

2022 Innovator Awardees

2022 Innovators

The lead investigators of the 2022 Innovator Awardees, pictured left to right: Becky Howsmon, Program Manager, Systems Education Experiences (Baliga Lab); Christian Diener, Research Scientist (Gibbons Lab); Miranda Johnson, Systems Thinkers in STEM Coordinator, Systems Education Experiences (Baliga Lab).

This year’s projects and awardees are:

Title: Demystifying Machine Learning for the High School Classroom
Lead Investigator: Becky Howsmon, Program Manager, Systems Education Experiences
ISB Collaborators: Miranda Johnson, Sevda Molani, Chris Lausted, and Annie Levine

Title: A Clinical and Experimental Exploration of Gut Microbiome-Statin Interactions
Lead Investigator: Christian Diener, Research Scientist
ISB Collaborators: Sevda Molani, Qi Wei, Noa Rappaport, Tomasz Wilmanski, Karl Gaisser, and Evan Pepper
External Collaborator: Johanna Lampe, Research Professor, Fred Hutchinson Cancer Research Center

Title: Advancing the Next Generation of Leaders in Science
Lead Investigator: Miranda Johnson, Systems Thinkers in STEM Coordinator, Systems Education Experiences
ISB Collaborators: Eliza Peterson, Mόnica Orellana, Gabriela Verdezoto Mosquera, Ulrike Kusebauch, Sevda Molani, Yeon Mi Hwang, Becky Howsmon, Claudia Ludwig, and Charu Midha

Visit the Innovator Award Program landing page to learn more.

Recent Articles

  • Gut Microbiome Composition Predictive of Patient Response to Statins

    New ISB research shows that different patient responses to statins can be explained by the variation in the human microbiome. The findings were published in the journal Med, and suggest that microbiome monitoring could be used to help optimize personalized statin treatments.

  • Risk Factors for Severe COVID-19 in Hospitalized Adults Differ by Age

    A just-published study provides new information about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die. The ISB-led work shows that vital signs and lab results at the time of hospital admission are the most accurate predictors of disease severity, more so than comorbidities and demographics.

  • Spotlight on ISB Education graphic

    2021-22 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.